Tickerplace logo

Tickerplace

Apellis Pharmaceuticals, Inc. logo

APLSApellis Pharmaceuticals, Inc.

APLS Stock Price, Valuation & Chart | Apellis Pharmaceuticals, Inc.

Compare
$41.030+0.00 (+0.00%)

At close · 15 May 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyAPLS intrinsic valueAPLS calculated fair value vs price
OverviewFinancialsDividendsRatios

APLS Historical price chart

APLS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization5.25B
PE Ratio38.35
EPS1.07
Trading Volume28.64M
Today's High/Low41.05/41.03
Dividend Yield0.00
52 Week High/Low41.14/16.61
Shares Outstanding128.02M
APLS Financial Statement
APLS Analyst ratings
APLS Analysis & performance metrics

APLS Company profile

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the…

APLS Management team

Management
Peter Hillmen M.D., Ph.D.
Head of Hematology Engagement & Member of PNH Scientific Advisory Board
David O. Watson Esq., J.D.
General Counsel & Secretary
Caroline R. Baumal M.D.
Chief Medical Officer
Pascal Deschatelets Ph.D.
Co-Founder & Chief Scientific Officer
Meredith Kaya
Senior Vice President, Investor Relations & Strategic Finance
Victoria L. Brown
Senior Vice President
Alec Machiels J.D., MBACTO
Co-Founder & Director
James G. Chopas CPA
Vice President, Corporate Controller & Chief Accounting Officer
Total 8 executives

APLS Frequently asked questions

What is Apellis Pharmaceuticals, Inc. (APLS) Stock Price?

Current stock price of Apellis Pharmaceuticals, Inc. (APLS) stock is $41.030. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Apellis Pharmaceuticals, Inc. (APLS) stock is 28.64M.

Last updated at 15 May 2026, 08:00 pm.

Why is the Apellis Pharmaceuticals, Inc. (APLS) stock price going up or down today?

The stock price of Apellis Pharmaceuticals, Inc. (APLS) can change with earnings, company news, and overall market sentiment. Apellis Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Apellis Pharmaceuticals, Inc. stock expensive at its current price?

Whether Apellis Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for APLS on this page is 38.35. EPS on this page is 1.07. Compare those figures with peers and growth expectations before deciding if the current Apellis Pharmaceuticals, Inc. price is justified.

How has the stock price of Apellis Pharmaceuticals, Inc. (APLS) performed historically?

Historical performance for Apellis Pharmaceuticals, Inc. (APLS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how APLS reacted to past earnings and market events.

Should I buy Apellis Pharmaceuticals, Inc. (APLS) stock, at this price?

Buying Apellis Pharmaceuticals, Inc. (APLS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.